ColoFIT At-Home Screening Collection Kits

Colon cancer is the third leading cause of cancer deaths in the U.S.—but it doesn’t have to be. Getting screened is the most powerful way to significantly reduce the odds of being diagnosed with colon cancer. With Labcorp’s at-home ColoFIT screening collection kits, you can empower your employees to get screened—all from the comfort and privacy of home.
36% of people say they’re more likely to complete an at-home colon cancer screening collection kit if it comes from their employer1
Routine screening is key to preventing colon cancer deaths

Did you know:

  • An estimated 60% of colon cancer deaths are preventable if everyone follows screening guidelines
  • Colon cancer screening is recommended for everyone between the ages of 45 and 75
  • Screening tests can detect early cancer or precancerous changes long before they cause symptoms, and while they’re still easy to treat
59% of people say they still haven’t acted on their plans to get screened for colorectal cancer1
A colon cancer screening program with at-home collection is an investment in your most valuable asset: your employees

While a colonoscopy remains the “gold standard” for screening, ColoFIT offers a trusted at-home screening collection option for people ages 45-75 at average risk.
How does ColoFIT work?

A fecal immunochemical test, or FIT, is a noninvasive screening test that uses antibodies to detect traces of blood in the stool that may be invisible to the naked eye. 

Labcorp’s ColoFIT test is a highly sensitive test and doesn’t require a large stool sample like other home screening methods. With a negative result, you can be 99.8% certain that no precancerous or cancer changes are taking place in the colon. 

A ColoFIT at-home screening collection kit requires no preparation or thick liquid drinks. Simply follow the instructions provided with the kit from the comfort and privacy of home. 

Individuals using ColoFITTM to screen for colorectal cancer should repeat FIT testing on an annual basis.
Labcorp ColoFIT screening programs for employers
Supporting preventive health programs for employees is one of the most significant investments you can make in your company’s future success—and empowering employee health across a large, decentralized workforce presents unique challenges. Labcorp makes it easy to encourage colon cancer screening with:

  • Easy online kit ordering and results sharing via WellConnect PlusTM
  • Comprehensive program results reporting 
  • Flexible, scalable program options 
  • A dedicated team of experts to maximize the success of your program
Resources

Read our blogs to learn more about colon cancer screening and the benefits of FIT testing.

Raising the voices of colorectal cancer screening

As new age guidelines emerge and more cases appear in people under 60, Labcorp and the Colorectal Cancer Alliance have teamed up to hear from 2,000 people who need screenings—working to identify where the barriers lie.


The Earlier the Better: Colon Cancer Screenings

With multiple testing options available, you are more empowered than ever to catch and prevent life-threatening diseases like colon cancer. Learn how to take proactive steps to keep your gut healthy.



Empower yourself with answers about colon cancer

Colon cancer. You might not want to think about it, but as the third leading cause of cancer deaths in adults in the United States, it is certainly worth talking about with your doctor. Let’s learn the basics and what you can do to improve your odds.


At-home FIT tests: How they help you detect colon cancer without getting a colonoscopy first

The American Cancer Society recommends that everyone ages 45 to 75 get screened for CRC.


Let’s talk about adding ColoFIT at-home screening kits to your employee health and wellness program.
We will handle your contact details in line with our Privacy Policy. If you prefer not to receive marketing emails from Labcorp, you can opt-out of all marketing communications or customize your preferences here.

© 2023 Laboratory Corporation of America® Holdings. All Rights Reserved.